Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Neurosci Lett
    August 2025
  1. WANG J, Hou J, Du M, Hou X, et al
    The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in Parkinson's disease through the Nrf2/HMOX1 pathway.
    Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338.
    >> Share

    July 2025
  2. DENG X, Zheng W, Xu H, Yang Y, et al
    Genetic analysis of TMEM230 variants in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2025 Jul 29:138334. doi: 10.1016/j.neulet.2025.138334.
    >> Share

    May 2025
  3. SUGIYAMA K, Kuroiwa M, Shuto T, Hwang S, et al
    Subregion-specific suppression of dopamine D1 receptor expression prevents L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2025 May 25:138273. doi: 10.1016/j.neulet.2025.138273.
    >> Share

  4. CORTES-ALTAMIRANO JL, Alfaro-Rodriguez A, Morraz-Varela A, Reyes-Long S, et al
    Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain caused by a persistent painful stimulus in Parkinsonian rats.
    Neurosci Lett. 2025;859-861:138270.
    >> Share

    January 2025
  5. ORTEGA A, Laville A, Padilla-Orozco M, Parrado Y, et al
    Cortical beta oscillation in brain slices of hemi parkinsonian mice.
    Neurosci Lett. 2025;849:138128.
    >> Share

    October 2024
  6. ZHANG J, Dong M, Li Z, Li Z, et al
    Association of plasma neurofilament light chain and Lipoprotein-related phospholipase A2 with motor subtypes of Parkinson's disease.
    Neurosci Lett. 2024 Oct 16:138011. doi: 10.1016/j.neulet.2024.138011.
    >> Share

  7. VILLAMAR-FLORES CI, Rodriguez-Violante M, Abundes-Corona A, Alatriste-Booth V, et al
    Association between alterations in sleep spindles and cognitive decline in persons with Parkinson's disease.
    Neurosci Lett. 2024;842:138006.
    >> Share

    September 2024
  8. BAGWELL E, Shin M, Henkel N, Migliaccio D, et al
    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a model for Parkinson's Disease.
    Neurosci Lett. 2024;842:137991.
    >> Share

  9. JIANG M, Liu Y, Cao Y, Liu Y, et al
    Auxiliary diagnostic method of Parkinson's disease based on eye movement analysis in a virtual reality environment.
    Neurosci Lett. 2024 Sep 2:137956. doi: 10.1016/j.neulet.2024.137956.
    >> Share

    August 2024
  10. ZHANG W, Peng H, Yang D, Song G, et al
    Absence of motor impairments or pathological changes in TMEM230 knockout rats.
    Neurosci Lett. 2024;837:137921.
    >> Share

  11. FAN X, Tang Y, Wei Z, Shi F, et al
    Mitochondrial dysfunction and NDUFS3: Insights from a PINK1(B9) Drosophila model in Parkinson's disease pathogenesis.
    Neurosci Lett. 2024 Aug 3:137917. doi: 10.1016/j.neulet.2024.137917.
    >> Share

    July 2024
  12. CHEN J, Meng Q, Zhang Y, Liang Y, et al
    TrueTH: A user-friendly deep learning approach for robust dopaminergic neuron detection.
    Neurosci Lett. 2024;836:137871.
    >> Share

  13. HE Q, Zhou Y, Jin J, Tian Q, et al
    Association between NEK1 gene polymorphisms and the potential risk of sporadic Parkinson's disease in the Chinese Northern Han population: A case-control study.
    Neurosci Lett. 2024 Jul 18:137913. doi: 10.1016/j.neulet.2024.137913.
    >> Share

    June 2024
  14. MENG Q, Chen J, Liang Y, Zhang X, et al
    miR-142-3p alleviates neuronal apoptosis in Parkinson's disease via negatively regulating C9orf72.
    Neurosci Lett. 2024 Jun 26:137887. doi: 10.1016/j.neulet.2024.137887.
    >> Share

  15. MARANO M, Altavista MC, Cassetta E, Brusa L, et al
    The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD post-hoc study.
    Neurosci Lett. 2024 Jun 7:137850. doi: 10.1016/j.neulet.2024.137850.
    >> Share

    April 2024
  16. ZAMEER F, Jain P, Khan K, Pramod Kumar P, et al
    Unraveling the regulatory landscape of Parkinson disease: A molecular symphony of miRNAs, transcription factors, and high-risk genes.
    Neurosci Lett. 2024 Apr 25:137792. doi: 10.1016/j.neulet.2024.137792.
    >> Share

    March 2024
  17. LI Z, Liu J, Miao X, Ge S, et al
    Reorganization of structural brain networks in Parkinson's disease with postural instability/gait difficulty.
    Neurosci Lett. 2024 Mar 19:137736. doi: 10.1016/j.neulet.2024.137736.
    >> Share

    February 2024
  18. SARKAR S, Biswas A, Ansari S, Choudhury S, et al
    Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
    Neurosci Lett. 2024;825:137706.
    >> Share

  19. ADLER CH, Serrano GE, Shill HA, Driver-Dunckley E, et al
    Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands.
    Neurosci Lett. 2024;825:137702.
    >> Share

  20. TAKIZAWA S, Ohuchi K, Fujimaki A, Ito T, et al
    Effects of alpha7 nicotinic acetylcholine receptor agonist against alpha-synuclein-induced neurotoxicity.
    Neurosci Lett. 2024;823:137654.
    >> Share

  21. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    >> Share

    January 2024
  22. LIU H, Gong Z, Li Z, Ye T, et al
    Distribution, connection and function of ALDH1A1(+)/TH(+) neurons in substantia nigra pars reticulata of mouse.
    Neurosci Lett. 2024;818:137555.
    >> Share

    December 2023
  23. HU Q, Xu L, Liu X, Wang Y, et al
    Adenosine A(2A) receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's disease mice by restoring autophagic flux.
    Neurosci Lett. 2023 Dec 27:137610. doi: 10.1016/j.neulet.2023.137610.
    >> Share

  24. HUANG W, Wang Y, Huang W
    Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
    Neurosci Lett. 2023 Dec 22:137608. doi: 10.1016/j.neulet.2023.137608.
    >> Share

  25. RAJAN S, Sood A, Jain R, Kamatham PT, et al
    Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease.
    Neurosci Lett. 2023;820:137596.
    >> Share

    November 2023
  26. BILISTER EGILMEZ C, Azak Pazarlar B, Alper Erdogan M, Erbas O, et al
    Neuroprotective effect of dexpanthenol on rotenone-induced Parkinson's disease model in rats.
    Neurosci Lett. 2023 Nov 29:137575. doi: 10.1016/j.neulet.2023.137575.
    >> Share

  27. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    >> Share

  28. SINGH A, Panhelainen A, Voutilainen MH
    Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration.
    Neurosci Lett. 2023;816:137510.
    >> Share

  29. PAN Y, Zong Q, Li G, Wu Z, et al
    Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits.
    Neurosci Lett. 2023;816:137490.
    >> Share

    October 2023
  30. MONAGHAN AS, Hooyman A, Dibble LE, Mehta SH, et al
    Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson's Disease at Fall-Risk.
    Neurosci Lett. 2023;817:137517.
    >> Share

    September 2023
  31. STATZ M, Schleuter F, Weber H, Kober M, et al
    Subthalamic nucleus deep brain stimulation does not alter growth factor expression in a rat model of stable dopaminergic deficiency.
    Neurosci Lett. 2023;814:137459.
    >> Share

  32. GENG X, Zou Y, Li J, Li S, et al
    Mesenchymal stem cell exosomes rich in miR-23b-3p affect the Wnt signaling pathway and promote neuronal autophagy to alleviate PD symptoms.
    Neurosci Lett. 2023;814:137437.
    >> Share

    August 2023
  33. HEO EJ, Lee Y, Hyung Seo M, Yeo S, et al
    Association between SGK1 and alpha-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2023 Aug 25:137464. doi: 10.1016/j.neulet.2023.137464.
    >> Share

  34. KAPLAN ALGIN A, Tomruk C, Gozde Aslan C, Saban Akkurt S, et al
    Effects of ozone treatment to the levels of neurodegeneration biomarkers after rotenone induced rat model of Parkinson's disease.
    Neurosci Lett. 2023;814:137448.
    >> Share

  35. HE P, Gao Y, Shi L, Li Y, et al
    Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.
    Neurosci Lett. 2023 Aug 8:137435. doi: 10.1016/j.neulet.2023.137435.
    >> Share

  36. TAN Z, Lin Y, Zhou M, Guo W, et al
    Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China.
    Neurosci Lett. 2023 Aug 4:137426. doi: 10.1016/j.neulet.2023.137426.
    >> Share

    July 2023
  37. TIAN Q, Sun X, Li C, Yang Y, et al
    CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
    Neurosci Lett. 2023;812:137400.
    >> Share

  38. LI Y, Li F, Liu X, Zu J, et al
    Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease.
    Neurosci Lett. 2023 Jul 10:137394. doi: 10.1016/j.neulet.2023.137394.
    >> Share

  39. JIN H, Shen H, Liu C, Wang L, et al
    Decreased Serum BDNF Contributes to the Onset of REM Sleep Behavior Disorder in Parkinson's Disease Patients.
    Neurosci Lett. 2023 Jul 7:137380. doi: 10.1016/j.neulet.2023.137380.
    >> Share

    June 2023
  40. HWAN SHIN J, Ah Shin D, Young Lee C, Jin Chang H, et al
    Inability to suppress head rotation during the saccade test as a clinical biomarker for cognitive dysfunction in Parkinson's disease.
    Neurosci Lett. 2023 Jun 22:137356. doi: 10.1016/j.neulet.2023.137356.
    >> Share

  41. ZHENG Q, Ma P, Yang P, Zhai S, et al
    Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Neurosci Lett. 2023 Jun 10:137346. doi: 10.1016/j.neulet.2023.137346.
    >> Share

    May 2023
  42. WANG X, Wei W, Bai Y, Shen Y, et al
    Intrinsic Brain Activity Alterations in Patients With Parkinson's disease.
    Neurosci Lett. 2023 May 15:137298. doi: 10.1016/j.neulet.2023.137298.
    >> Share

    April 2023
  43. ZHANG X, Zhong X, Wang L, Li H, et al
    Effects of soluble TREM2 on motor progression in Parkinson's disease.
    Neurosci Lett. 2023 Apr 25:137277. doi: 10.1016/j.neulet.2023.137277.
    >> Share

  44. ZHANG X, Li L, Qi L, Fu Y, et al
    Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
    Neurosci Lett. 2023 Apr 13:137249. doi: 10.1016/j.neulet.2023.137249.
    >> Share

  45. SHIDA TKF, de Oliveira CEN, da Silva Fragoso de Campos D, Los Angeles E, et al
    Effect of freezing of gait and dopaminergic medication in the biomechanics of lower limbs in the gait of patients with Parkinson's disease compared to neurologically healthy.
    Neurosci Lett. 2023;806:137250.
    >> Share

  46. MURAKAMI Y, Nishijima H, Nakamura T, Furukawa T, et al
    Altered amantadine effects after repetitive treatment for l-dopa-induced involuntary movements in a rat model of Parkinson's disease.
    Neurosci Lett. 2023;806:137248.
    >> Share

  47. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    >> Share

  48. MA C, Wei X, Wang F, Zhang T, et al
    Tumor necrosis factor alpha-induced protein 3 mediates inflammation and neuronal autophagy in Parkinson's disease via the NFkappaB and mTOR pathways.
    Neurosci Lett. 2023 Apr 3:137223. doi: 10.1016/j.neulet.2023.137223.
    >> Share

  49. MORRISON S, Reilly N, Schussler E, Kerr G, et al
    The effect of standing posture on amplitude and variability of postural tremor in Parkinson's disease.
    Neurosci Lett. 2023 Apr 3:137220. doi: 10.1016/j.neulet.2023.137220.
    >> Share

  50. YUAN M, Du N, Song Z
    Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: a study based on MRS and Q-Space.
    Neurosci Lett. 2023 Apr 3:137224. doi: 10.1016/j.neulet.2023.137224.
    >> Share

    March 2023
  51. GOMEZ-MARTIN A, Fuentes JM, Jordan J, Galindo MF, et al
    Detection of rare Genetic Variations in the promoter regions of the ATG16L gene in Parkinson's patients.
    Neurosci Lett. 2023 Mar 21:137195. doi: 10.1016/j.neulet.2023.137195.
    >> Share

  52. LI W, Pan X, Li M, Ling L, et al
    Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster.
    Neurosci Lett. 2023 Mar 13:137187. doi: 10.1016/j.neulet.2023.137187.
    >> Share

    February 2023
  53. OMAR AHMAD S, Longhurst J, Stiles D, Downard L, et al
    A meta-analysis of exercise intervention and the effect on Parkinson's Disease Symptoms.
    Neurosci Lett. 2023 Feb 28:137162. doi: 10.1016/j.neulet.2023.137162.
    >> Share

  54. CARNEY AE, Clarke C, Pratt WE
    Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by alpha-flupenthixol.
    Neurosci Lett. 2023;797:137069.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016